Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials01:16

Clinical Trials

6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
6.6K
Ethics in Research01:56

Ethics in Research

22.9K
Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
22.9K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

124
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
124
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

1.2K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.2K
Blind Procedures02:07

Blind Procedures

10.6K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
10.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A national survey of clinical informatics educational opportunities in United States medical schools.

Journal of the American Medical Informatics Association : JAMIA·2026
Same author

Symptom-based rehabilitation in people with post-COVID-19 condition (RELOAD study): a randomised controlled trial.

BMJ open respiratory research·2026
Same author

Large Language Model Performance and Clinical Reasoning Tasks.

JAMA network open·2026
Same author

Small intestinal microbial fiber metabolism dysfunction in celiac disease.

Nature communications·2026
Same author

RapidParc: A global-context transformer for parallel, accurate, and lesion-robust tractogram parcellation.

Imaging neuroscience (Cambridge, Mass.)·2026
Same author

Cardiac risk, outcomes, and management among older adults with stage I-II non-small cell lung cancer undergoing stereotactic body radiation therapy.

Journal of geriatric oncology·2026

Related Experiment Video

Updated: Jun 16, 2025

Remotely Supervised Transcranial Direct Current Stimulation: An Update on Safety and Tolerability
08:22

Remotely Supervised Transcranial Direct Current Stimulation: An Update on Safety and Tolerability

Published on: October 7, 2017

8.1K

Public Perspectives on Direct-to-Consumer Testing Oversight.

Sharon Jiang1,2, David Lebo3, Thomas Schultz3

  • 1School of Pharmacy, Temple University, Philadelphia, PA, USA. sharon.jiang@temple.edu.

Therapeutic Innovation & Regulatory Science
|August 17, 2024
PubMed
Summary
This summary is machine-generated.

The FDA finalized a rule for laboratory developed tests (LDTs), phasing out enforcement discretion for most LDTs but exempting direct-to-consumer (DTC) tests. Public comments highlighted concerns, especially regarding DTC testing.

Keywords:
DTC regulationDTC testDirect-to-consumerFDA enforcement discretionFDA proposed rule on LDT

More Related Videos

Working with Human Tissues for Translational Cancer Research
07:48

Working with Human Tissues for Translational Cancer Research

Published on: November 26, 2015

9.9K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.2K

Related Experiment Videos

Last Updated: Jun 16, 2025

Remotely Supervised Transcranial Direct Current Stimulation: An Update on Safety and Tolerability
08:22

Remotely Supervised Transcranial Direct Current Stimulation: An Update on Safety and Tolerability

Published on: October 7, 2017

8.1K
Working with Human Tissues for Translational Cancer Research
07:48

Working with Human Tissues for Translational Cancer Research

Published on: November 26, 2015

9.9K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.2K

Area of Science:

  • Medical Device Regulation
  • Clinical Diagnostics
  • Public Health Policy

Background:

  • The U.S. Food and Drug Administration (FDA) published a final rule on May 6, 2024, concerning Medical Devices; Laboratory Developed Tests (LDTs).
  • This rule amends regulations to ensure the safety and effectiveness of LDTs.
  • It signifies a shift away from the FDA's previous general enforcement discretion policy for LDTs, aligning them with In Vitro Diagnostic Devices.

Purpose of the Study:

  • To analyze public reactions and concerns regarding the proposed FDA rule on LDTs.
  • To specifically examine issues related to direct-to-consumer (DTC) testing within the new regulatory framework.
  • To provide recommendations for improving the regulation and oversight of LDTs, particularly DTC tests.

Main Methods:

  • Analysis of public comments submitted during the rule-making process (proposed October 3, 2023).
  • Focus on commentary concerning DTC tests and hybrid DTC models.
  • Review of existing FDA policies and regulatory approaches for diagnostic tests.

Main Results:

  • The final rule exempts DTC testing from the policy shift, citing existing applicable requirements.
  • Significant public commentary revealed key concerns and suggestions regarding the LDT rule.
  • The commentary highlights a need to reassess enforcement discretion for hybrid DTC tests and clarify clinical oversight.

Conclusions:

  • Recommendations include reassessing FDA enforcement discretion for hybrid DTC tests.
  • Advocating for clear regulatory guidance on clinical oversight for LDTs is essential.
  • Prioritizing a risk-based enforcement approach and enhancing public education on DTC testing risks are crucial for public health protection.